Literature DB >> 8175709

The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems.

C Plank1, B Oberhauser, K Mechtler, C Koch, E Wagner.   

Abstract

The process by which viruses destabilize endosomal membranes in an acidification-dependent manner has been mimicked with synthetic peptides that are able to disrupt liposomes, erythrocytes, or endosomes of cultured cells. Peptides containing the 20 amino-terminal amino acid sequence of influenza virus hemagglutinin as well as acidic derivatives showed erythrocyte lysis activity only when peptides were elongated by an amphipathic helix or by carboxyl-terminal dimerization. Interestingly, peptides consisting of the 23 amino-terminal amino acids of influenza virus hemagglutinin were also active in erythrocyte lysis. When peptides were incorporated into DNA complexes that utilize a receptor-mediated endocytosis pathway for uptake into cultured cells, either by ionic interaction with positively charged polylysine-DNA complexes or by a streptavidin-biotin bridge, a strong correlation between pH-specific erythrocyte disruption activity and gene transfer was observed. A high-level expression of luciferase or interleukin-2 was obtained with optimized gene transfer complexes in human melanoma cells and several cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175709

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

1.  Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems.

Authors:  J Y Cherng; H Talsma; D J Crommelin; W E Hennink
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.

Authors:  I Freulon; A C Roche; M Monsigny; R Mayer
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  A novel transfecting peptide comprising a tetrameric nuclear localization sequence.

Authors:  Wolfgang Ritter; Christian Plank; James Lausier; Carsten Rudolph; Daniela Zink; Dietrich Reinhardt; Joseph Rosenecker
Journal:  J Mol Med (Berl)       Date:  2003-10-22       Impact factor: 4.599

5.  Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells.

Authors:  Antoine Kichler; Christian Leborgne; Josefine März; Olivier Danos; Burkhard Bechinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-31       Impact factor: 11.205

6.  Efficient active transport of gene nanocarriers to the cell nucleus.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

Review 7.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

8.  Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.

Authors:  J A Hughes; A I Aronsohn; A V Avrutskaya; R L Juliano
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 9.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

10.  Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.

Authors:  Angela A Alexander-Bryant; Anca Dumitriu; Christopher C Attaway; Hong Yu; Andrew Jakymiw
Journal:  J Control Release       Date:  2015-09-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.